zepbound tirzepatide weight loss news

FDA, Zepbound and obstructive sleep apnea

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

People on MSN · 1d

Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.

CNN on MSN · 6d

FDA approves weight-loss drug Zepbound for obstructive sleep apnea

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

14hon MSN

The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

rheumatologyadvisor15d

Tirzepatide Bests Semaglutide in Head-to-Head Weight Loss Trial

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

ABC News19d

Zepbound users discuss weight loss after preliminary research touts effectiveness

Zepbound is a medication containing tirzepatide, which the preliminary study showed to be more effective for weight loss than Wegovy, which contains semaglutide. This preliminary study ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA, Zepbound and obstructive sleep apnea

Trending now